Axel Grothey, MD, West Cancer Center & Research Institute
Advertisement
Articles by Axel Grothey, MD, West Cancer Center & Research Institute
Advertisement
Latest Updated Articles
Role of I/O Combination Therapies in mCRCPublished: June 29th 2020 | Updated:
Later Lines of Therapy for mCRCPublished: June 29th 2020 | Updated:
Therapeutic Agents in Relapsed/Refractory mCRCPublished: June 29th 2020 | Updated:
Using I/O in MSI-H Tumors in mCRCPublished: June 29th 2020 | Updated:
Key Trials in mCRC: I/O Combination TherapiesPublished: June 29th 2020 | Updated:
Second-Line Treatment for mCRCPublished: June 29th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
2
Treatment Individualization Is Increasingly Vital With T-DXd Poised to Enter Early-Stage HER2+ Breast Cancer Paradigm
3
FDA Approves Guardant360 as Encorafenib Companion Diagnostic in BRAF V600E-Mutant mCRC
4
INAVO123 Set to Determine Upfront Role of Inavolisib in PIK3CA-Mutant, HR+ Breast Cancer
5